STELLA, GIULIA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.441
AS - Asia 2.343
EU - Europa 1.601
SA - Sud America 512
AF - Africa 159
OC - Oceania 4
Totale 7.060
Nazione #
US - Stati Uniti d'America 2.330
SG - Singapore 695
CN - Cina 606
VN - Vietnam 400
BR - Brasile 387
HK - Hong Kong 312
IT - Italia 301
RU - Federazione Russa 288
DE - Germania 203
IE - Irlanda 198
FR - Francia 154
FI - Finlandia 146
ZA - Sudafrica 114
GB - Regno Unito 95
IN - India 95
CA - Canada 57
AR - Argentina 51
BD - Bangladesh 43
NL - Olanda 42
MX - Messico 35
SE - Svezia 30
AT - Austria 28
IQ - Iraq 28
JP - Giappone 23
CO - Colombia 20
PL - Polonia 20
CZ - Repubblica Ceca 19
EC - Ecuador 18
ES - Italia 18
TR - Turchia 18
PK - Pakistan 16
ID - Indonesia 14
MA - Marocco 14
PH - Filippine 13
LT - Lituania 12
UA - Ucraina 11
VE - Venezuela 11
SA - Arabia Saudita 10
CL - Cile 9
AZ - Azerbaigian 8
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
KE - Kenya 6
BE - Belgio 5
JM - Giamaica 5
UZ - Uzbekistan 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
KG - Kirghizistan 4
NP - Nepal 4
TH - Thailandia 4
AU - Australia 3
BO - Bolivia 3
IR - Iran 3
KH - Cambogia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
LV - Lettonia 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
AL - Albania 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
NI - Nicaragua 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TJ - Tagikistan 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
LB - Libano 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
Totale 7.051
Città #
Singapore 377
San Jose 300
Hong Kong 295
Ashburn 292
Dallas 284
Beijing 210
Dublin 198
Chandler 147
Ho Chi Minh City 145
Los Angeles 102
Johannesburg 101
Munich 98
Lauterbourg 97
Hanoi 88
New York 87
Milan 83
Turku 74
Helsinki 68
Boardman 63
Redondo Beach 56
Moscow 47
São Paulo 44
Shanghai 41
Montreal 29
Pavia 29
Buffalo 28
Orem 27
Atlanta 26
Da Nang 26
Falkenstein 26
Council Bluffs 25
Santa Clara 24
Stockholm 24
Chennai 23
Chicago 23
Tokyo 23
Nuremberg 21
Princeton 20
Wilmington 20
Denver 19
Frankfurt am Main 19
Lawrence 19
London 18
Brooklyn 17
Medford 17
Warsaw 17
Mexico City 16
Phoenix 16
Seattle 15
Turin 15
Brno 13
Columbus 13
Haiphong 13
Paris 13
Poplar 13
Rio de Janeiro 13
Vienna 13
Biên Hòa 12
Düsseldorf 12
Hyderabad 12
Manchester 12
Nanjing 12
The Dalles 12
Boston 11
Houston 11
Jacksonville 11
San Francisco 10
Shenyang 10
Amsterdam 9
Ankara 9
Baghdad 9
Changsha 9
Guangzhou 9
Toronto 9
Bắc Ninh 8
Curitiba 8
Elk Grove Village 8
Nanchang 8
Querétaro 8
Rubiera 8
Baku 7
Belo Horizonte 7
Brasília 7
Buenos Aires 7
Florence 7
Guayaquil 7
Porto Alegre 7
Pune 7
Rome 7
Saluzzo 7
Washington 7
Cape Town 6
Mumbai 6
New Delhi 6
Ninh Bình 6
Olomouc 6
Tianjin 6
Zhengzhou 6
Amman 5
Asunción 5
Totale 4.326
Nome #
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 172
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 149
5-hydroxymethylcytosine but not MTAP methylation status can stratify malignant pleural mesothelioma based on the lineage of origin 130
Clinical utility of CD4+ function assessment (ViraCor-IBT ImmuKnow test) in lung recipients 127
Athletic protocol in non-cystic fibrosis-related bronchiectasis: rationale and design of the pilot ATHOS study 125
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients 122
Smoking Habit and Respiratory Function Predict Patients' Outcome after Surgery for Lung Cancer, Irrespective of Histotype and Disease Stage 119
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 116
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche 111
From interconnection between genes and microenvironment to novel immunotherapeutic approaches in upper gastro-intestinal cancers—A multidisciplinary perspective 107
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 104
Case Report: All That Glisters Is Not* Cancer 103
CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency 100
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 98
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 98
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 98
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 97
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 97
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 96
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience 95
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 95
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 95
Unexpected responses to EGFR inhibition in NSCLC 94
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 92
Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets 90
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 88
CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned 87
From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective 86
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives 85
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 84
A 28-Year-Old Man with Stridor and Dyspnea 84
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 83
Radiographic findings in 240 patients with COVID-19 pneumonia: time-dependence after the onset of symptoms 83
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 82
Bayesian Networks in the Management of Hospital Admissions: A Comparison between Explainable AI and Black Box AI during the Pandemic † 82
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study 81
Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer 76
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection 75
Phenotyping sarcoidosis: a single institution retrospective analysis 75
Phenotypes and Serum Biomarkers in Sarcoidosis 74
A Rare Case of Exophiala Dermatitidis Isolation in a Patient with Non-Cystic Fibrosis Bronchiectasis: Colonization or True Infection? 74
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and Design 72
COVID-19 epidemic in a Respiratory Diseases Unit: predictor ranking and mining 71
Asbestos and Mesothelioma 70
Radiomics features as predictive and prognostic biomarkers in NSCLC 69
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 68
Predictive markers associated to fibrotic evolution in hypersensitivity pneumonitis: a single institution's analysis 67
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 66
The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review 65
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 64
Pulmonary Infiltrates in a Non-Cystic Fibrosis Bronchiectasis Patient: A Case Report 63
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab 63
Partition analysis of data of two waves of COVID-19 pandemic: is the landscape really evolving? A single institution experience 63
MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin 62
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis 62
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 61
Radiomics features as predictive and prognostic biomarkers in NSCLC 61
Adaptations in maximal oxygen consumption and lower-limb muscle oxygen extraction capacity following 4 months of moderate-intensity training in Parkinson's disease: a pilot study 60
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease 60
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 57
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 57
Diagnostic role of internal mammary lymph node involvement in tuberculous pleurisy: a multicenter study 56
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 56
Management of severe pneumonia in respiratory non-intensive care unit: a retrospective study from a single center experience 56
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review 55
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction 55
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 55
RON tyrosine kinase mutations in brain metastases from lung cancer 55
A case report of primary signet ring cell carcinoma of the lung: Imaging study and literature review 53
Molecular Diagnostic Yield and Safety Profile of Ultrasound-Guided Lung Biopsies: A Cross-Sectional Study 52
Phenotyping Bronchiectasis Frequent Exacerbator: A Single Centre Retrospective Cluster Analysis 52
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma 52
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? 51
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 49
From COPD to Smoke-Related Arteriopathy: The Mechanical and Immune–Inflammatory Landscape Underlying Lung Cancer Distant Spreading—A Narrative Review 49
A non-small cell lung cancer fragile elderly patient treated with immunotherapy and non-ablative radiation therapy: a case report of a winning combination 49
Extracellular vesicles isolated from adipose tissue-derived mesenchymal stromal cells as carriers for Paclitaxel delivery 47
Cancers of unknown primary origin: Current perspectives and future therapeutic strategies 47
Evolving concepts in COPDand lung cancer: a narrative review 45
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype 44
Lung disease recalling paraseptal emphysema in a patient with Goltz syndrome 43
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma 42
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis 42
Carbon nanotubes and pleural damage: Perspectives of nanosafety in the light of asbestos experience 39
Caveolin-1 as a promoter of tumour spreading: When, how, where and why 39
Incidence of Tracheal Stenosis in ICU Hospitalized COVID-19 Patients: Results from a Prospective, Observational, Multicenter Study 38
Epidermal growth factor receptor and caveolin-1 coexpression identifies adult supratentorial ependymomas with rapid unfavorable outcomes 37
The Role of Antifibrotic Therapy in Pulmonary Fibrosis and Lung Cancer: A Multicenter Retrospective Analysis 37
Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses 36
Lung-Seeking Metastases 36
Telomeropathies: an emerging spectrum of disorders with important implications for patients with interstitial lung disease 35
Non-neuronal cholinergic system in airways and lung cancer susceptibility 35
Lung tumors, COPD and immune response: is epigenetics the bottom line? 32
Sex and gender differences during the lung lifespan: unveiling a pivotal impact 30
Lymph-node mapping in lung cancer staging: accuracy and limits of the current approaches 29
Reply to Althuwaybi et al 28
Surgical options to early-stage lung cancer: can "the less" mean "the safe"? 27
Prolonged-release oxycodone-naloxone for pain management in advanced EGFR wild-type lung cancer patients 26
Idiopathic pulmonary fibrosis landscapes: looking glass from pathology to therapy 25
New Updates of the Imaging Role in Diagnosis, Staging, and Response Treatment of Malignant Pleural Mesothelioma 25
Totale 6.969
Categoria #
all - tutte 28.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.224


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 2 0 0
2021/2022104 19 0 0 2 1 6 0 7 7 4 12 46
2022/2023476 39 37 1 51 37 33 0 23 222 2 26 5
2023/2024404 44 55 19 23 52 85 32 21 5 12 9 47
2024/20251.693 40 43 30 64 40 173 98 104 398 114 199 390
2025/20264.401 304 425 426 717 599 181 707 258 475 309 0 0
Totale 7.207